Device and method for dispensing at least one substance
ZA201902553B
Crystalline forms
TW201932460A
Crystalline forms of (3S,4S)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide
US2020347029A1
C5a receptor modulators
CN111683937A
C5a receptor modulators
EP3740493A1
Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase
AR114564A1
DERIVATIVES OF 2,4,6,7-TETRAHIDRO-PIRAZOLO [3,4-D] PYRIMIDIN-ONA AS MODULATORS OF THE C5a RECEPTOR AND THE PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM
CA3083327A1
Combination of a 4-pyrimidinesulfamide derivative with an sglt-2 inhibitor for the treatment of endothelin related diseases